Spk-8011: Preliminary Results from a Phase 1/2 Dose Escalation Trial of an Investigational AAV-Mediated Gene Therapy for Hemophilia a

被引：0
|
作者：
George, Lindsey A.
Ragni, Margaret V.
Samelson-Jones, Ben J.
Cuker, Adam
Runoski, Alexa R.
Cole, Grace
Wright, Fraser
Chen, Yifeng
Hui, Daniel J.
Wachtel, Katie
Takefman, Daniel
Couto, Linda B.
Reape, Kathleen Z.
Carr, Marcus E.
Anguela, Xavier M.
High, Katherine A.
机构：
来源：
BLOOD | 2017年 / 130卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
604
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Updated results of Transpher A, a multicenter, single-dose, Phase 1/2 clinical trial of ABO-102 investigational gene therapy for Sanfilippo syndrome type A (mucopolysaccharidosis IIIA)
    Flanigan, K. M.
    Smith, N. J. C.
    Couce, M. L.
    Escolar, M.
    Truxal, K. V.
    McBride, K. L.
    de Castro, M. J.
    Fuller, M.
    Paneda, A.
    Ruiz, J.
    del Campo, A. B.
    Grachev, I. D.
    NEUROLOGY, 2022, 98 (18)
  • [42] AAV8 Gene Therapy as a Potential Treatment in Adults with Late-Onset OTC Deficiency: Results from a Phase 1/2 Clinical Trial
    Tan, Wen-Hann
    Geberhiwot, Tarekegn
    Couce, Maria Luz
    Aldamiz-Echevarria, Luis
    Diaz, George A.
    Harding, Cary O.
    Khan, Aneal
    Lee, Connie
    Puga, Ana Cristina
    Crombez, Eric
    MOLECULAR THERAPY, 2020, 28 (04) : 222 - 222
  • [43] Phase 1-2 Trial of AAVS3 Gene Therapy in Patients with Hemophilia B
    Chowdary, Pratima
    Shapiro, Susan
    Makris, Mike
    Evans, Gillian
    Boyce, Sara
    Talks, Kate
    Dolan, Gerard
    Reiss, Ulrike
    Phillips, Mark
    Riddell, Anne
    Peralta, Maria R.
    Quaye, Michelle
    Patch, David W.
    Tuddenham, Edward
    Dane, Allison
    Watissee, Marie
    Long, Alison
    Nathwani, Amit
    NEW ENGLAND JOURNAL OF MEDICINE, 2022, 387 (03): : 237 - 247
  • [44] Phase 1-2 Trial of AAVS3 Gene Therapy in Patients with Hemophilia B
    Chowdary, Pratima
    Nathwani, Amit
    NEW ENGLAND JOURNAL OF MEDICINE, 2022, 387 (14): : 1336 - 1337
  • [45] Latest results from the COMPOSE® Phase 1/2 trial of pegtibatinase, a novel investigational enzyme replacement therapy for classical homocystinuria (HCU)
    Ganesh, J.
    Thomas, J.
    Smith, W.
    Lah, M.
    Kudrow, D.
    Guner, J.
    McDermott, S.
    Vaidya, S.
    Wilkening, L.
    Levy, H.
    Ficicioglu, C.
    MOLECULAR GENETICS AND METABOLISM, 2024, 141 : 15 - 15
  • [46] AAV2-hCHM Subretinal Delivery to the Macula in Choroideremia: Preliminary Six Month Safety Results of an Ongoing Phase I/II Gene Therapy Trial
    Aleman, Tomas S.
    Serrano, Leona
    Han, Grace K.
    Pearson, Denise J.
    McCague, Sarah
    Marshall, Kathleen A.
    Chung, Daniel C.
    Liu, Emily
    Morgan, Jessica Ijams Wolfing
    Bennett, Jean
    Maguire, Albert M.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2017, 58 (08)
  • [47] Systemic dose-finding study with AAV-Mediated gamma-sarcoglycan gene therapy for treatment of muscle deficits in LGMD2C Mice
    Seo, Y.
    Kempton, A.
    Rogers, O.
    Baine, S.
    Lewis, S.
    Adegboye, K.
    Haile, A.
    Griffin, D.
    Peterson, E.
    Pozsgai, E.
    Rodino-Klapac, L.
    NEUROMUSCULAR DISORDERS, 2020, 30 : S87 - S87
  • [48] Phase 1/2 dose escalation and dose expansion study of TransCon IL-2 b/g alone or in combination with pembrolizumab: Initial results from dose escalation
    Starodub, Alexander
    Powderly, John D.
    Kim, Sung-Bae
    Davar, Diwakar
    Hill, Andrew Graham
    Yeku, Oladapo O.
    Gabrail, Nashat Y.
    Krapp, Christian
    Pihl, Susanne
    Zhang, Ying
    Slavsky, Sibel
    Castro, Davis Y. Torrejon
    Uyei, Anne
    Singel, Stina Mui
    Kwatra, Vineet
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [49] COHORT 1-4 RESULTS FROM A PHASE 1/2 CLINICAL TRIAL OF AN AAV8-MEDIATED LIVER-DIRECTED GENE THERAPY IN ADULTS WITH GLYCOGEN STORAGE DISEASE TYPE IA (GSDIA)
    Rodriguez-Buritica, David F.
    Ahmad, Ayesha
    Pico, Maria-Luz Couce
    Derks, Terry G.
    Mitchell, John
    Riba-Wolman, Rebecca
    Weinstein, David A.
    Lee, Connie
    Valayannopoulos, Vassili
    Crombez, Eric
    MOLECULAR GENETICS AND METABOLISM, 2022, 135 (04) : 296 - 296
  • [50] Initiation of Oral Steroid Therapy Produced Rapid Normalization of Transaminase Levels and Stabilization of FIX Activity in Subjects Who Developed T-Cell Responses in the SPK-9001: AAV Gene Transfer for Hemophilia B Phase 1/2 Trial
    George, L.
    Sullivan, S.
    Giermasz, A.
    Ducore, J.
    Rasko, J.
    Teitel, J.
    Cuker, A.
    Samelson-Jones, B.
    Sullivan, L.
    Majumdar, S.
    Mcguinn, C.
    Galvao, A.
    HAEMOPHILIA, 2017, 23 : 15 - 16
12345